Most hospitals treat pharmacy as a necessary overhead. We treat it as an untapped lever — for cost control, clinical quality, and accreditation readiness. RxOptimise Solutions builds the systems, governance, and clinical capability to make that shift happen.
The gap between what South African hospital pharmacy could deliver and what it actually delivers is a governance problem — not a staffing one. The right systems, clinical frameworks, and data infrastructure change the equation entirely.
NDM-1 and ESBL-producing organisms are spreading through Gauteng hospitals. Formularies are expanding without P&T governance. NHI data obligations are active. Most hospital pharmacy teams are operating without the clinical or operational infrastructure to manage any of it systematically.
That is the gap we close.
Not frameworks imported from abroad. Services shaped around the realities of Mediclinic, Netcare, Life Healthcare, provincial DOH structures, and the NHI transition reshaping both sectors.
Polypharmacy is quietly driving readmissions and adverse events in your wards. We implement structured MTM programmes that catch problems before they escalate — cutting ADR incidence, shortening length of stay, and protecting your medico-legal position.
A pharmacist-led AMS programme cuts antibiotic spend, slows carbapenem resistance, and satisfies COHSASA governance requirements simultaneously. We design, implement, and audit them end to end.
SAHPRA reporting is tighter than most teams realise. We build surveillance pipelines that are actually used — not compliance theatre. Signal detection, causality assessment, and reporting that protects patients and institutions.
An unmanaged formulary is a budget leak. We build P&T committee governance that sticks — STG-aligned, evidence-based substitution policies, and review cycles that clinical staff actually follow.
Stockouts and wastage running simultaneously. Long turnaround times. We map, redesign, and implement — from inpatient dispensing to automated dispensing cabinet advisory and SOP frameworks.
PK–PD modelling for precision dosing in critical care, e-prescribing system advisory, data-driven medication audits, and KPI dashboards that put pharmacy performance in the boardroom conversation.
Each pillar delivers standalone value. Together, they compound. A hospital that improves formulary governance, builds AMS capability, and invests in analytics is a categorically different institution three years later.
The clinical core of what we do — direct engagement with medication management, stewardship governance, and pharmacovigilance. It anchors patient safety outcomes and protects your institution from the categories of risk that generate litigation, adverse event reports, and accreditation findings.
Operational inefficiency in pharmacy is expensive and invisible until it isn't. Long turnaround times affect clinical workflows in ways that ward teams attribute to everything except the pharmacy. We find where time and money are being lost — and redesign accordingly.
Consulting that does not build institutional capability is just renting a solution. Every engagement includes a deliberate knowledge transfer component — formal SAPC CPD-aligned programmes, clinical skills workshops, and medication safety training for nursing staff.
This is where pharmacy stops being a back-office function and starts appearing in executive reporting. PK–PD modelling for critical care dosing, e-prescribing system advisory, data-driven medication audits, and KPI dashboards that put pharmacy performance where it belongs — in the boardroom.
Engagements are led by senior clinical pharmacist consultants who understand PK–PD modelling, AMS governance, and formulary economics at depth — not junior associates following a methodology deck.
Pharmacy consulting that only speaks to pharmacists does not drive institutional change. We translate clinical pharmacy into financial outcomes and governance language that board-level conversations require.
We understand the gap between a Life Healthcare acute facility and a Level 3 provincial hospital. Our recommendations are realistic, not theoretical — and tailored to your actual environment.
Every engagement includes deliberate knowledge transfer. The goal is an institution that does not need us for the same problem two years later.
Hospital executives who are still treating pharmacy as a self-managing cost centre will face accreditation findings, NHI contracting exposure, and preventable clinical incidents. The question is not whether to invest in pharmacy governance — it is whether to do it reactively or strategically.
Let's have that conversation
We engage with hospital executives, pharmacy managers, and clinical leads who have identified a problem and want to understand what solving it actually looks like — in time, cost, and capability terms.
The initial scoping session is structured, confidential, and without obligation. If we cannot add value, we will tell you.